Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.58 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.40 |
| ▸ | CASR | P41180 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | P2RY10 | O00398 | 2/20 | 0.33 |
| ▸ | GPR174 | Q9BXC1 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Serine SCHEMBL10612187 | 0.88 | SLC7A5 (0.45) | SLC7A5SLC1A3SLC1A2SLC1A1CASR | |
| Isoleucine SCHEMBL1899454 | 0.88 | SLC7A5 (0.45) | SLC7A5SLC1A3SLC1A2SLC1A1ACHE | |
| SCHEMBL2702062 | 0.87 | SLC7A5 (0.46) | SLC7A5SLC1A3SLC1A2SLC1A1CASR | |
| SCHEMBL288383 | 0.85 | SLC7A5 (0.44) | SLC7A5SLC1A3SLC1A2SLC1A1CASR | |
| SCHEMBL8988392 | 0.85 | SLC1A3 (0.48) | SLC7A5SLC1A3SLC1A2SLC1A1CASR | |
| SCHEMBL9118329 | 0.85 | SLC1A3 (0.48) | SLC7A5SLC1A3SLC1A2SLC1A1CASR | |
| SCHEMBL6038226 | 0.85 | SLC7A5 (0.44) | SLC7A5SLC1A3SLC1A2SLC1A1CASR | |
| SCHEMBL18050156 | 0.85 | SLC7A5 (0.44) | SLC7A5SLC1A3SLC1A2SLC1A1CASR | |
| SCHEMBL23286474 | 0.84 | SLC7A5 (0.48) | SLC7A5SLC1A3SLC1A2SLC1A1CASR | |
| SCHEMBL1514131 | 0.84 | SLC7A5 (0.48) | SLC7A5SLC1A3SLC1A2SLC1A1CASR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0210257-A4 | PROTEIN WHICH IS CHARACTERISTIC OF RHEUMATOID ARTHRITIS. | HURWITZ CHARLES (US) | 1988-01-20 | — | — | EP | claimed |
| EP-0210257-A1 | PROTEIN WHICH IS CHARACTERISTIC OF RHEUMATOID ARTHRITIS | HURWITZ, Charles (US) | 1987-02-04 | — | — | EP | claimed |
| WO-1986004588-A1 | PROTEIN WHICH IS CHARACTERISTIC OF RHEUMATOID ARTHRITIS | HURWITZ CHARLES (US) | 1986-08-14 | — | — | WO | claimed |
| CN-118308092-A | Eu3+/Tb3+Fluorescent sensor for preparing amino acid by doping protein eutectic, method and application | 青岛大学 | 2024-07-09 | — | — | CN | disclosed |
| US-RE49583-E1 | Inducible expression systems | TET SYSTEMS GMBH & CO. KG (DE) | 2023-07-18 | — | — | US | disclosed |
| CN-112469729-A | Analgesic and method of use | 悉尼大学 | 2021-03-09 | — | — | CN | disclosed |
| US-20190117840-A1 | TISSUE SCAFFOLDS | Northwick Park Institute for Medical Research Ltd. (GB) | 2019-04-25 | — | — | US | disclosed |
| EP-3439709-A1 | TISSUE SCAFFOLDS | Northwick Park Institute For Medical Research Ltd (GB) | 2019-02-13 | — | — | EP | disclosed |
| WO-2017174965-A1 | TISSUE SCAFFOLDS | NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH LTD RESEARCH LTD (GB) | 2017-10-12 | — | — | WO | disclosed |
| EP-2802661-A1 | MUTATED CEPHALOSPORIN HYDROXYLASE AND ITS APPLICATION IN DEACETYLCEPHALOSPORANIC ACID SYNTHESIS | Orchid Chemicals and Pharmaceuticals Ltd (IN) | 2014-11-19 | — | — | EP | disclosed |
| CN-101304758-B | Recombinant interferon Alpha2 (IFNAlpha2) mutants | YEDA RES & DEV | 2013-08-21 | — | — | CN | disclosed |
| EP-1989221-A2 | NOVEL LIPASES AND USES THEREOF | DSMIP Assets B.V. (NL) | 2008-11-12 | — | — | EP | disclosed |
| EP-1954811-A2 | INDUCIBLE EXPRESSION SYSTEMS | Academisch Medisch Centrum (NL) | 2008-08-13 | — | — | EP | disclosed |
| WO-2007096201-A2 | NOVEL UPASES AND USES THEREOF | DSM IP ASSETS B.V. (NL) | 2007-08-30 | — | — | WO | disclosed |
| WO-2007058527-A2 | INDUCIBLE EXPRESSION SYSTEMS | ACADEMISCH MEDISCH CENTRUM (NL) | 2007-05-24 | — | — | WO | disclosed |
| US-6428624-B1 | MIXTURE OF REDUCING SUGAR AND BASE CATALYST; MIXTURE ENRICHED IN AT LEAST ONE AMINO ACID OF SERINE, THREONINE, VALINE, LEUCINE AND ISOLEUCINE | R. J. REYNOLDS TOBACCO CO. | 2002-08-06 | — | — | US | disclosed |
| US-20020074008-A1 | Method of providing flavorful and aromatic compounds | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2002-06-20 | — | — | US | disclosed |
| CN-1034416-Y | With comfortable kinin antagonists for the preparation method of peptide | He toru spa | 1997-04-02 | — | — | CN | disclosed |
| CN-1131561-A | Macrostem onion active extract | DUAN CHANGXIANG (CN) | 1996-09-25 | — | — | CN | disclosed |
| WO-1996003158-A1 | USE OF LOW MOLECULAR WEIGHT AMINO ACIDS IN OPHTHALMIC COMPOSITIONS | ALCON LABORATORIES, INC. (US) | 1996-02-08 | — | — | WO | disclosed |